A new study has shown that susceptibility to a series of blood cancers, known as myeloproliferative disorders (MPDs), is linked to a particular area of the patient's DNA, which is prone to developing mutations.
Full article >>
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment